Disease Long-Term Care Facilities Treatment 
The Pharma Data
DECEMBER 17, 2020
Regardless of their decisions or which treatment they receive, all participants will be monitored for two years. It’s going to change everyone’s behavior otherwise,” suggested Hayley Gans, a pediatrics and infectious diseases expert at Stanford University Medical Center.
The Pharma Data
DECEMBER 19, 2020
Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) voted today to recommend the use of the Moderna COVID-19 vaccine in people 18 years of age and older under the Emergency Use Authorization (EUA) issued by the U.S. .–( BUSINESS WIRE )– Moderna, Inc., AUTHORIZED USE.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Pharma Data
APRIL 14, 2021
government for its neutralizing antibody therapies authorized for emergency use as a treatment for COVID-19. Lilly subsequently developed bamlanivimab and etesevimab for administration together, in order to meet the potential challenge of SARS-CoV-2 variants likely to resist treatment with either monoclonal antibody used alone.
The Pharma Data
OCTOBER 28, 2020
Lilly submitted a request for an EUA for bamlanivimab for the treatment of mild to moderate COVID-19 in high-risk patients to the FDA in early October. Bamlanivimab emerged from the collaboration between Lilly and AbCellera to create antibody therapies for the prevention and treatment of COVID-19. Food and Drug Administration (FDA).
The Pharma Data
FEBRUARY 1, 2021
million shots have now been administered in long-term care facilities, according to the U.S. Centers for Disease Control and Prevention. The variant is perhaps the most worrisome to public health experts, because it seems to have some ability to evade COVID-19 antibody treatments or vaccines.
The Pharma Data
DECEMBER 10, 2020
Centers for Disease Control and Prevention will also vote on whether to recommend the vaccine and for whom, the Post reported. First in line are health care personnel and residents and staff of long-term care facilities, according to earlier recommendations released by the CDC panel.
The Pharma Data
JUNE 25, 2021
While COVID-19 vaccination efforts have been successful, there is still a significant need for prevention and treatment options for certain populations, including those unable to be vaccinated or those who may have an inadequate response to vaccination.”. Preliminary analyses show similar adverse events in the placebo and treatment arms.
Expert insights. Personalized for you.
Let's personalize your content